Yüklüyor......
Vasopressin in chronic kidney disease, an elephant in the room?
The report by Perico et al that a dual arginine vasopressin (AVP) V2 and V1a receptor antagonist lowers blood pressure, proteinuria and glomerulosclerosis in 5/6 nephrectomized rats points to a potential therapeutic value of AVP receptor antagonists in the treatment of chronic kidney disease (CKD)....
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2925670/ https://ncbi.nlm.nih.gov/pubmed/19829311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2009.325 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|